Clinical trials
ART clinical trials
Below are recruiting art clinical trials, each written for real people, not researchers. We’re tracking 138 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07033052Recruiting
Art therapy for anxiety and depression in teens
This trial tests whether art-based activities can help children and teens aged 8 to 17 who feel anxious or depressed. Parents must agree to let their child join.
Cleveland, OhioAges 8–17 - NCT07014267Recruiting
Virtual reality for calming anxiety during fertility procedures
This trial tests whether using virtual reality (VR) for mindfulness can help reduce anxiety in people undergoing fertility-related surgeries. If you are between 18 and 50 and scheduled for a fertility procedure, you may be able to participate.
Abu DhabiAges 18–50 - NCT06774872RecruitingPhase 2
Comparing two-drug HIV maintenance treatments
This trial compares a two-drug regimen of doravirine and lamivudine to another two-drug regimen of dolutegravir and lamivudine for people with HIV who have had a suppressed viral load for at least 24 months. The goal is to see if the newer combination works as well as the current one.
Paris, Île-de-France RegionAges 18 years+ - NCT06183983Recruiting
Advanced MRI for better glioblastoma radiation
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
Rotterdam, South HollandAges 18 years+ - NCT06949774Recruiting
Text reminders to help with HIV medication adherence
This study tests whether daily text message reminders and a small tracking device (WisePill) can help people who recently started HIV medication stay on track. It's designed for people who began treatment in the past 2 months and are willing to receive texts and use the device.
KampalaAges 18 years+ - NCT06908083Enrolling by invitationPhase 1
Stopping HIV treatment with antibody therapy
This trial tests whether a combination of powerful antibodies (bNAbs) can help control HIV after stopping standard HIV treatment. Participants will pause their daily HIV medications while receiving these antibodies, and doctors will closely monitor their immune system and virus levels. It's for people who are already well-controlled on HIV treatment and have participated in a specific earlier study.
Bethesda, MarylandAges 18–70 - NCT06910293Recruiting
Brain Activity During Menstrual Cycle vs. Fertility Treatment
This study looks at how natural menstrual cycles and ovarian stimulation (which mimics some fertility treatments) affect brain activity and hormone levels. Researchers want to understand normal brain changes during the cycle to help improve fertility treatments.
Abu Dhabi, Abu Dhabi EmirateAges 25–35 - NCT06605053Recruiting
Improving HIV care for pregnant teens and young women in Tanzania
This trial aims to improve HIV prevention and treatment for pregnant adolescents and young women in Tanzania. It includes reviewing medical records, talking to patients and providers, and testing new care approaches.
Dar es SalaamAges 15 years+ - NCT06839274Recruiting
Follicle size and egg maturity in poor responders
This trial looks at how the size of ovarian follicles (fluid sacs that contain eggs) affects egg maturity in women who have a low egg count. It may help improve egg freezing or IVF success.
Abu Dhabi, Abu Dhabi EmirateAges 18–48 - NCT06827795Recruiting
Testing a new surgical tool for spine surgery
This study compares a new surgical tool, the Surgify Halo, to a standard tool used in spine surgery. It aims to see which is easier to use and performs better for removing bone during spine surgery.
New York, New YorkAges 21–85 - NCT06829394Recruiting
Housing help for people with HIV in Philadelphia
This study looks at how stable housing can improve the health of people with HIV. If you're in Philadelphia and eligible for a transitional housing program, you may be able to participate and help researchers understand the impact.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06786871Enrolling by invitation
ARTLifeLine: A study of IVF family health and development
This study follows people who have had or plan to have IVF treatment to understand the long-term health and development of their families. You may be able to join if you have IVF medical records available.
Beijing, Beijing MunicipalityAges birth–50 years - NCT06771843Recruiting
Helping men with HIV reduce drinking and improve HIV prevention
This study tests whether helping men with HIV who also drink heavily can lower their alcohol use and improve how well HIV treatment works to prevent passing the virus to others. It's for men living in fishing communities in Uganda.
KampalaAges 18 years+ - NCT06732843Recruiting
Comparing two IVF medications for egg and embryo quality
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
Abu Dhabi, Abu Dhabi EmirateAges 18–38 - NCT06770972Recruiting
Parenting support for IVF and ART families
This study tests a virtual class for people who became pregnant through fertility treatments like IVF. The class aims to help you and your caregiving partner build a strong foundation for your family.
Los Angeles, CaliforniaAges 18 years+ - NCT06762730RecruitingPhase 4
Zoledronic acid to prevent bone loss from HIV treatment
This trial tests if zoledronic acid, a drug that strengthens bones, can prevent bone loss caused by starting HIV treatment. It is for people newly diagnosed with HIV who have not yet taken any HIV medication.
HaifaAges 18 years+ - NCT06745050Recruiting
Motivation Matters! study for HIV treatment
This study tests a program called Motivation Matters! to help people with HIV who have traded sex for things they need get started on HIV medication and stay healthy. It uses text messages to support you.
NairobiAges 18 years+ - NCT06659315Recruiting
Preventing HIV transmission from mom to baby for depressed mothers in Malawi
This study tests a program to help pregnant women with HIV who also have depression, and their partners, reduce the risk of passing HIV to their babies. The program includes support for mental health and HIV care.
ZombaAges 18 years+ - NCT06650033Recruiting
Pelvic adaptive radiotherapy study
This trial tests a special type of radiation called adaptive radiotherapy for people with certain pelvic cancers. Adaptive radiotherapy adjusts the treatment plan each day based on changes in your body, which may help target the cancer more precisely and reduce side effects.
St Leonards, New South WalesAges 18 years+ - NCT06572930Recruiting
Monitoring FSH for better ovarian stimulation
This study looks at whether tracking a hormone called FSH during ovarian stimulation can help find the best level for egg development. It may help improve your chances in fertility treatment.
Abu Dhabi, Abu Dhabi EmirateAges 18–39 - NCT06551038Recruiting
Suicide prevention program for at-risk teens
This study tests a new program to help prevent suicide in teens and young adults who face extra challenges. It is designed for those who are already struggling with mental health, school, detention, or other tough life situations.
Geneva, Canton of GenevaAges 14–25 - NCT06526520Recruiting
Relaxin levels in frozen embryo transfer preparation
This study looks at a hormone called relaxin during different ways of preparing the uterus for a frozen embryo transfer. It may help understand which preparation method works best for women who are not trying to get pregnant right now.
Abu Dhabi, Abu Dhabi EmirateAges 18–35 - NCT06497465RecruitingPhase 3
Two-drug HIV treatment for people with TB
This trial tests a two-drug HIV treatment for people who are new to HIV therapy and also have tuberculosis. It compares the two-drug combination to the standard three-drug regimen, with the goal of making treatment simpler while still being effective.
Manaus, AmazonasAges 15–99 - NCT06484335RecruitingPhase 1
HIV vaccine study with treatment pause for Thai adults
This study tests whether adding an experimental vaccine can help your immune system control HIV during a temporary break from your antiretroviral therapy (ART). If you have been on ART since shortly after infection with a suppressed viral load, this trial could help you understand if a 'functional cure' is possible.
Pathum Wan, BangkokAges 18–60
Hear when a new ART trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for art?
- Yes. Clin2 currently lists 138 recruiting art studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a art trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a art trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.